Aims: Prognostic analysis of hepatocellular carcinoma (HCC) in the cirrhotic patient undergoing hepatic resection is necessary in order to determine the clinical effect of hepatectomy on prognosis. Patients and methods: Univariate and multivariate retrospective analyses were performed in 51 cirrhotic patients (38 men, 13 women; mean age 65 years, range 43-81 years) with supervening HCC undergoing hepatic resection between January 1993 and December 1997. Results: Segmental liver resection was performed in 39 patients (76%) with non-anatomical (wedge) resections in the remainder of cases. The post-operative mortality rate was 8%. The tumours recurred in 23 patients (45%), with 12 patients (52% of recurrences) recurring within 1 year of surgery and 22 patients (96% of recurrences) within 3 years. Recurrent disease was most frequently intrahepatic (22 patients). Significant risk factors for recurrence were micro/ macro vascular invasion, and symptoms. Conclusions: The recurrence rate of hepatocellular carcinoma in patients with cirrhosis undergoing surgical resection alone is high and actuarial survival at 4 years is low. Other approaches to the treatment of hepatocellular carcinoma in patients with cirrhosis require consideration.
Introduction

Patients and methods
The prevalence of cirrhosis in hepatocellular carcinoma Fifty-one cirrhotic patients (38 men, 13 women; mean age (HCC) patients ranges from 60 to 90%. 1 Frequent 65 years, range 43-81 years) underwent hepatic resection monitoring with ultrasonography (US) and -fetoprotein for supervening HCC in the Department of Emergency (AFP) levels have made it possible to discover small tumours Surgery at the University of Milan between January 1993 (Ζ2 cm in maximal diameter) in patients with cirrhosis and December 1997. Their clinical features and demographic and chronic viral hepatitis.
2 Surgical resection with partial characteristics are summarized in Table 1 . hepatic resection or liver transplantation are the only Thirty-eight patients (74%) were asymptomatic, with potentially curative treatments. [3] [4] [5] [6] However, hepatic HCC being discovered by US during routine follow-up for resection can only be offered to patients with good liver cirrhosis. The remainder of cases (26%) were symptomatic. function and well-defined, solitary tumours treatable with Abdominal pain and upper gastrointestinal haemorrhage limited hepatic resection. Liver transplantation is the only were the most frequently presenting symptoms. Nineteen option in patients with poor liver function or in nonpatients (37%) had hepatitis C virus, 11 (21%) hepatitis C resectable tumour(s), provided extrahepatic malignancy has plus hepatitis B virus, 10 (20%) isolated hepatitis B virus, been excluded. eight (16%) alcoholic cirrhosis and three (6%) cryptogenic The present study details experience in our institution cirrhosis. Each case was classified according to the gained in the surgical resection of HCC in patients with Child-Pugh criteria for hepatic functional reserve. 7 All cirrhosis.
patients were also evaluated with indocyanine green retention 8 at 15 min as predictor of liver reserve. Thirtyeight patients (74%) were in Child's group A, 12 (24%) in Child's group B, and one (2%) in Child's group C. relation to clinical and pathological characteristics of the tumour and type of cirrhosis was evaluated. The parameters used in the univariate analysis were as follows: sex, age, and two nodules of HCC in seven patients (14%) with a cirrhosis aetiology, presence or absence of alcoholism, mean size of 6±3 cm. Abdominal computed tomography hepatitis C virus, hepatitis B surface antigen, symptoms, (CT) with intravenous contrast was performed in 45 patients AFP level, type of resection and hepatic resection margin (88%) and showed one main tumour in 35 cases (78%), two (more or less than 1 cm), tumour size and number, type of separate nodules in nine (20%), and three nodules in one tumour, satellite nodules, tumour differentiation, tumour case (2%). Satellite lesions, defined as a minute contrast capsule, capsule invasion, vascular invasion, and presence enhancement near the primary lesion, were occasionally of associated dysplasia. detected in 12 subjects (26%).
Segmental resection was performed in 39 patients (76%), while the remaining 12 patients (24%) underwent nonAnalysis of the data anatomical (wedge) resection. Three patients (6%) had repeat hepatic resections because of tumour recurrence Overall and disease-free survival analyses were conducted in the hepatic remnant. Intra-operative ultrasonography using the Kaplan-Meier method, 11 with comparisons (IOUS) was used in 31 patients (61%). At operation the between groups performed by the log-rank test. 12 Diseasetumour could not be located by inspection or palpation in free survival was estimated from the date of the hepatic 12 patients (24%) but was found by IOUS. This examination resection to the date of diagnosis of recurrent disease using detected additional nodules in one patient who had been US, CT scan, hepatic angiography or biopsy. Multivariate diagnosed as having a solitary tumour before surgery.
analysis using Cox's logistic regression technique 13 was Cirrhosis was histologically confirmed in all patients.
employed for variables found to be significant on univariate Patients were staged according to the UICC TNM analysis. Statistical significance is recorded for P-values classification for HCC. 10 Thirty-nine patients had a clear surgical margins of more than 1 cm, and Results 12 patients had a clear surgical margin of less than 1 cm. There were no patients with hepatic resection margin involved.
There were four peri-operative deaths (8%). Three patients All patients with HCC complicating their cirrhosis were died from hepatic failure and one from post-operative resected for cure. The mean tumour size was 6±4 cm in myocardial infarction. Post-operative ascites occurred in maximal diameter (Table 2 ). According to the UICC TNM seven patients with progressive hepatorenal syndrome in staging, seven patients (14%) were stage 1, 18 (35%) stage one case. Major peri-operative complications occurred in 2, 18 (35%) stage 3A, and eight (16%) stage 4A.
20% of cases including severe gastrointestinal bleeding in one, cardiopulmonary complications in three, significant Follow-up but reversible hepatic failure in five, and abdominal wound dehiscence in one. All cases were followed at 4-month intervals with serial AFP levels, US and CT scanning. Recurrence of HCC in
The mean hospital stay was 13 days (range 6-36 days). The mean follow-up was 28 months (range 4-60 months).
The 1-year, 3-year and 4-year overall and disease-free and 30%, respectively (Fig. 1) . Recurrent HCC was diagnosed in 23 patients (45%) with 12 patients (52% of recurrences) recurring within 1 year of surgery and 22 patients (96% of recurrences) within 3 years. and 100, 73 and 73%, respectively, in those cases without vascular invasion (P<0.0001) (Fig. 2) . Recurrent disease was most frequently detected in the liver parenchyma, usually as a solitary tumour near the resection The 1-year, 3-year and 4-year disease-free survival rates for patients with vascular invasion were 40, 13 and 13%, margin.
Extrahepatic recurrences were detected in four cases respectively, and 79, 46 and 38%, respectively, in those cases without vascular invasion (P<0.005). (17%), all presenting with solitary lung metastases (Table  3) .
Four patients with microscopic vascular invasion developed recurrence within 1 year following surgery and Tumour size did not affect either overall survival or disease-free survival. The 4-year overall survival rates for three-quarters of those with microvascular invasion (12 patients) died within 3 years of hepatectomy. tumours <2 cm, 2-5 cm and >5 cm in maximal diameter were 50, 60 and 40%, respectively. The 4-year disease-free
The 1-year, 3-year and 4-year overall survival rates for patients with a solitary tumour were 92, 66 and 66%, survival rates for tumours <2 cm, 2-5 cm and >5 cm in maximal diameter were 17, 36 and 27%, respectively. respectively, whereas equivalent survival rates for patients with more than one tumour were 78, 11 and 11%, respectively Histologic vascular invasion was found to be a relevant prognostic factor for overall and disease-free survival. The (P<0.01) (Fig. 3) . The 1-year, 3-year and 4-year disease-free survival rates 1-year, 3-year and 4-year overall survival rates for patients with vascular invasion were 67, 15 and 15%, respectively, for patients with a solitary tumour were 71, 41 and 35%,
Discussion and conclusions
Strict follow-up of patients with cirrhosis, mainly by US examination, has increased the frequency of diagnosis of small resectable HCC. 2, 4 This is reflected in this series by the fact that 74% of patients were asymptomatic and detected on routine follow-up US. Hepatectomy appears to be relatively safe even in cirrhotic patients with supervening HCC with an overall mortality of 8% in our series. Moreover, the 5-year survival in such patients is between 33 and 46% in most Western countries 1, 14, 15 and 25 and 33% in reported Asian series. [16] [17] [18] Intra-operative ultrasonography is a valuable tool not only for detecting the tumour, but also for establishing adequate resection margins sparing as much parenchyma as possible. [19] [20] [21] [22] In this study, 24% of tumours were not has an acceptable morbidity in cirrhosis complicated by supervening HCC.
25-27
There has been considerable improvement in the prediction of the safety of liver resection in selected patients with cirrhosis and impaired hepatic Table 4 . Multivariate analysis of prognostic variables affecting overall survival and disease-free survival in 51 cirrhotic patients reserve; 28, 29 however, tumour recurrence during follow-up in following hepatic resection for hepatocellular carcinoma this group is common. 17,23, 30 The recurrence rate in this series was 49% in patients surviving surgery, and was similar to
that of other series. 3, 18, 31, 32 The cumulative recurrence rate at 3 years was 57% in our study and was similar to that The majority of tumour recurrences in our study were This has been a similar finding in other studies concerning cirrhotics with supervening HCC 35,36 as well as in HCC patients without cirrhosis, 37 where intrahepatic recurrence most commonly follows small non-anatomical resections. respectively, compared with 44, 11 and 11%, respectively, for patients presenting with multiple tumours (P<0.05).
The most significant prognostic factors reported for recurrence have included: more than one primary tumour, The 1-year, 3-year and 4-year overall survival rates for patients with a symptomatic tumour were 80, 0 and 0%, tumour size greater than 2 cm in maximal diameter, the presence of a tumour capsule, and vascular invasion. 3, 30, [38] [39] [40] [41] [42] respectively, whereas equivalent survival for patients with an asymptomatic tumour were 91, 63 and 63%, respectively In the present series of cirrhotic subjects, tumour size was not a significant prognostic factor and the presence of (P<0.05) (Fig. 4) .
The 1-year, 3-year and 4-year disease-free survival rates tumour encapsulation did not reach significance. Vascular invasion and symptomatic tumours were significant for patients with a symptomatic tumour were 40, 0 and 0%, compared with 73, 41 and 35%, respectively, for patients prognostic factors in multivariate analysis, which correlated with recurrence. This highlights the importance of close with an asymptomatic tumour (P<0.05).
To clarify the significance of each significant parameter follow-up in patients with cirrhosis in order to detect asymptomatic tumours. by univariate analysis, multiple logistic regression analysis was carried out with Cox's proportional hazard model.
If tumour recurrence occurs, there are several treatment options 43 depending on several parameters such as size and Table 4 shows the result of multivariate analysis assessing vascular invasion, multiple tumour and symptomatic location of the tumour, number of tumour nodules and functional hepatic reserve. One option is to repeat the tumour.
The type of cirrhosis, presence or absence of a tumour hepatic resection and survival in these cases has been as high as 75% at 3 years. 32 Ringe et al. 44 have found a high capsule, surgical resection margin or tumour grading did not affect either overall survival or disease-free survival on incidence of HCC recurrence with re-resection, and they have proposed liver transplantation in cases of resectable univariate analysis. 
